Educating CD4 T cells with vaccine adjuvants: Lessons from lipopolysaccharide

Trends in Immunology

Volumn 31, Issue 11, 2010, Pages 429-435

  McAleer, Jeremy P ^a,b   Vella, Anthony T ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR; VACCINE;

ANTIGEN PRESENTING CELL; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CROSS PRESENTATION; HUMAN; INTESTINE MUCOSA; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE MIGRATION; LYMPHOID TISSUE; NONHUMAN; REVIEW; TH1 CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; HUMANS; LIPOPOLYSACCHARIDES; TOLL-LIKE RECEPTORS; VACCINES;

EID: 78049239398     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2010.08.005     Document Type: Review

References (94)

1. Kawai T., Akira S. TLR signaling. Semin. Immunol. 2007, 19:24-32.
2. Hoebe K., et al. Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways. Nat. Immunol. 2003, 4:1223-1229.
3. McAleer J.P., Vella A.T. Understanding how lipopolysaccharide impacts CD4 T-cell immunity. Crit. Rev. Immunol. 2008, 28:281-299.
4. Tokoyoda K., et al. Professional memory CD4+ T lymphocytes preferentially reside and rest in the bone marrow. Immunity 2009, 30:721-730.
5. McAleer J.P., et al. The lipopolysaccharide adjuvant effect on T cells relies on nonoverlapping contributions from the MyD88 pathway and CD11c+ cells. J. Immunol. 2007, 179:6524-6535.
6. Gretz J.E., et al. Lymph-borne chemokines and other low molecular weight molecules reach high endothelial venules via specialized conduits while a functional barrier limits access to the lymphocyte microenvironments in lymph node cortex. J. Exp. Med. 2000, 192:1425-1440.
7. Yang Y., et al. Heat shock protein gp96 is a master chaperone for toll-like receptors and is important in the innate function of macrophages. Immunity 2007, 26:215-226.
8. Rossi R.J., et al. Staphylococcal enterotoxins condition cells of the innate immune system for Toll-like receptor 4 stimulation. Int. Immunol. 2004, 16:1751-1760.
9. Yadav R., et al. Effects of LPS-mediated bystander activation in the innate immune system. J. Leukoc. Biol. 2006, 80:1251-1261.
10. Itano A.A., et al. Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity. Immunity 2003, 19:47-57.
11. Longhi M.P., et al. Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant. J. Exp. Med. 2009, 206:1589-1602.
12. Sporri R., Reis e Sousa C. Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function. Nat. Immunol. 2005, 6:163-170.
13. Zanin-Zhorov A., et al. Cutting edge: T cells respond to lipopolysaccharide innately via TLR4 signaling. J. Immunol. 2007, 179:41-44.
14. Caramalho I., et al. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J. Exp. Med. 2003, 197:403-411.
15. Lewkowicz P., et al. Lipopolysaccharide-activated CD4+CD25+ T regulatory cells inhibit neutrophil function and promote their apoptosis and death. J. Immunol. 2006, 177:7155-7163.
16. Bendigs S., et al. CpG-oligodeoxynucleotides co-stimulate primary T cells in the absence of antigen-presenting cells. Eur. J. Immunol. 1999, 29:1209-1218.
17. Gelman A.E., et al. Toll-like receptor ligands directly promote activated CD4+ T cell survival. J. Immunol. 2004, 172:6065-6073.
18. Komai-Koma M., et al. TLR2 is expressed on activated T cells as a costimulatory receptor. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:3029-3034.
19. Caron G., et al. Direct stimulation of human T cells via TLR5 and TLR7/8: flagellin and R-848 up-regulate proliferation and IFN-gamma production by memory CD4+ T cells. J. Immunol. 2005, 175:1551-1557.
20. Cottalorda A., et al. TLR2 engagement on CD8 T cells lowers the threshold for optimal antigen-induced T cell activation. Eur. J. Immunol. 2006, 36:1684-1693.
21. Gelman A.E., et al. The adaptor molecule MyD88 activates PI-3 kinase signaling in CD4+ T cells and enables CpG oligodeoxynucleotide-mediated costimulation. Immunity 2006, 25:783-793.
22. LaRosa D.F., et al. T cell expression of MyD88 is required for resistance to Toxoplasma gondii. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:3855-3860.
23. Rahman A.H., et al. MyD88 plays a critical T cell-intrinsic role in supporting CD8 T cell expansion during acute lymphocytic choriomeningitis virus infection. J. Immunol. 2008, 181:3804-3810.
24. Zhao Y., et al. The adaptor molecule MyD88 directly promotes CD8 T cell responses to vaccinia virus. J. Immunol. 2009, 182:6278-6286.
25. Asprodites N., et al. Engagement of Toll-like receptor-2 on cytotoxic T-lymphocytes occurs in vivo and augments antitumor activity. FASEB J. 2008, 22:3628-3637.
26. Ishii K.J., Akira S. Toll or toll-free adjuvant path toward the optimal vaccine development. J. Clin. Immunol. 2007, 27:363-371.
27. Watts T.H. TNF/TNFR family members in costimulation of T cell responses. Annu. Rev. Immunol. 2005, 23:23-68.
28. Mata-Haro V., et al. The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4. Science 2007, 316:1628-1632.
29. McAleer J.P., et al. Lipopolysaccharide potentiates effector T cell accumulation into nonlymphoid tissues through TRIF. J. Immunol. 2009, 182:5322-5330.
30. Gasperini S., et al. Gene expression and production of the monokine induced by IFN-gamma (MIG), IFN-inducible T cell alpha chemoattractant (I-TAC), and IFN-gamma-inducible protein-10 (IP-10) chemokines by human neutrophils. J. Immunol. 1999, 162:4928-4937.
31. Khan I.A., et al. IP-10 is critical for effector T cell trafficking and host survival in Toxoplasma gondii infection. Immunity 2000, 12:483-494.
32. Hokeness K.L., et al. CXCR3-dependent recruitment of antigen-specific T lymphocytes to the liver during murine cytomegalovirus infection. J. Virol. 2007, 81:1241-1250.
33. Mikhak Z., et al. Endotoxin augmented antigen-induced Th1 cell trafficking amplifies airway neutrophilic inflammation. J. Immunol. 2009, 182:7946-7956.
34. Kaufman D.R., Barouch D.H. Translational mini-review series on vaccines for HIV: T lymphocyte trafficking and vaccine-elicited mucosal immunity. Clin. Exp. Immunol. 2009, 157:165-173.
35. Thompson C.B., et al. CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines. Proc. Natl. Acad. Sci. U. S. A. 1989, 86:1333-1337.
36. Armitage R.J., et al. CD40 ligand is a T cell growth factor. Eur. J. Immunol. 1993, 23:2326-2331.
37. Havenar-Daughton C., et al. Cutting Edge: The direct action of type I IFN on CD4 T cells is critical for sustaining clonal expansion in response to a viral but not a bacterial infection. J. Immunol. 2006, 176:3315-3319.
38. Wan Y.Y., Flavell R.A. How diverse-CD4 effector T cells and their functions. J. Mol. Cell Biol. 2009, 1:20-36.
39. Eisenbarth S.C., et al. Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J. Exp. Med. 2002, 196:1645-1651.
40. den Haan J.M., et al. Cutting edge: lipopolysaccharide induces IL-10-producing regulatory CD4+ T cells that suppress the CD8+ T cell response. J. Immunol. 2007, 178:5429-5433.
41. McAleer J.P., et al. Potent intestinal Th17 priming through peripheral lipopolysaccharide-based immunization. J. Leukoc. Biol. 2010, 88:21-31.
42. Cucak H., et al. Type I interferon signaling in dendritic cells stimulates the development of lymph-node-resident T follicular helper cells. Immunity 2009, 31:491-501.
43. Michetti M., et al. Gastric mucosal alpha(4)beta(7)-integrin-positive CD4 T lymphocytes and immune protection against helicobacter infection in mice. Gastroenterology 2000, 119:109-118.
44. Ciabattini A., et al. Intranasal immunization with vaccine vector Streptococcus gordonii elicits primed CD4+ and CD8+ T cells in the genital and intestinal tracts Vaccine 2010, 28:1226-1233.
45. Masopust D., et al. Dynamic T cell migration program provides resident memory within intestinal epithelium. J. Exp. Med. 2010, 207:553-564.
46. Kaufman D.R., et al. Trafficking of antigen-specific CD8+ T lymphocytes to mucosal surfaces following intramuscular vaccination. J. Immunol. 2008, 181:4188-4198.
47. Iwata M., et al. Retinoic acid imprints gut-homing specificity on T cells. Immunity 2004, 21:527-538.
48. Agace W.W. T-cell recruitment to the intestinal mucosa. Trends Immunol. 2008, 29:514-522.
49. Ross A.C., et al. Augmentation of antibody responses by retinoic acid and costimulatory molecules. Semin. Immunol. 2009, 21:42-50.
50. Kang S.G., et al. Identification of a chemokine network that recruits FoxP3(+) regulatory T cells into chronically inflamed intestine. Gastroenterology 2007, 132:966-981.
51. Kunisawa J., et al. Sphingosine 1-phosphate dependence in the regulation of lymphocyte trafficking to the gut epithelium. J. Exp. Med. 2007, 204:2335-2348.
52. Khader S.A., et al. Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa. Mucosal Immunol. 2009, 2:403-411.
53. Cowley S.C., et al. Lung CD4-CD8- double-negative T cells are prominent producers of IL-17A and IFN-gamma during primary respiratory murine infection with Francisella tularensis live vaccine strain. J. Immunol. 2010, 184:5791-5801.
54. Malley R., et al. Antibody-independent, interleukin-17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide. Infect. Immun. 2006, 74:2187-2195.
55. Lu Y.J., et al. Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog. 2008, 4(9):e1000159.
56. Velin D., et al. Interleukin-17 is a critical mediator of vaccine-induced reduction of Helicobacter infection in the mouse model. Gastroenterology 2009, 136:2237-2246.
57. Datta, S.K. et al. (2010) Mucosal adjuvant activity of cholera toxin requires Th17 cells and protects against inhalation anthrax. Proc. Natl. Acad. Sci. U. S. A. 107, 10638-10643 [year missing].
58. Lee J.B., et al. Intranasal delivery of cholera toxin induces th17-dominated T-cell response to bystander antigens. PLoS One 2009, 4(4):e5190.
59. Challacombe S.J., Tomasi T.B. Systemic tolerance and secretory immunity after oral immunization. J. Exp. Med. 1980, 152:1459-1472.
60. Zygmunt B.M., et al. Intranasal immunization promotes th17 immune responses. J. Immunol. 2009, 183:6933-6938.
61. McLachlan J.B., Jenkins M.K. Migration and accumulation of effector CD4+ T cells in nonlymphoid tissues. Proc. Am. Thorac. Soc. 2007, 4:439-442.
62. Bajenoff M., Guerder S. Homing to nonlymphoid tissues is not necessary for effector Th1 cell differentiation. J. Immunol. 2003, 171:6355-6362.
63. Ivanov I.I., et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006, 126:1121-1133.
64. Atarashi K., et al. ATP drives lamina propria T(H)17 cell differentiation. Nature 2008, 455:808-812.
65. Hall J.A., et al. Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses. Immunity 2008, 29:637-649.
66. Ivanov I.I., et al. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 2008, 4:337-349.
67. Niess J.H., et al. Commensal gut flora drives the expansion of proinflammatory CD4 T cells in the colonic lamina propria under normal and inflammatory conditions. J. Immunol. 2008, 180:559-568.
68. Uematsu S., et al. Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing Toll-like receptor 5. Nat. Immunol. 2008, 9:769-776.
69. Denning T.L., et al. Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses. Nat. Immunol. 2007, 8:1086-1094.
70. Becker C., et al. Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells. J. Clin. Invest. 2003, 112:693-706.
71. Coombes J.L., et al. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J. Exp. Med. 2007, 204:1757-1764.
72. Sun C.M., et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 2007, 204:1775-1785.
73. Korn T., et al. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 2007, 448:484-487.
74. Das J., et al. Transforming growth factor beta is dispensable for the molecular orchestration of Th17 cell differentiation. J. Exp. Med. 2009, 206:2407-2416.
75. Santarlasci V., et al. TGF-beta indirectly favors the development of human Th17 cells by inhibiting Th1 cells. Eur. J. Immunol. 2009, 39:207-215.
76. Nurieva R., et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 2007, 448:480-483.
77. McGeachy M.J., et al. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat. Immunol. 2007, 8:1390-1397.
78. Wei G., et al. Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity 2009, 30:155-167.
79. Mangan P.R., et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006, 441:231-234.
80. Lee Y.K., et al. Late developmental plasticity in the T helper 17 lineage. Immunity 2009, 30:92-107.
81. Zhou L., et al. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 2008, 453:236-240.
82. Tsuji M., et al. Preferential generation of follicular B helper T cells from Foxp3+ T cells in gut Peyer's patches. Science 2009, 323:1488-1492.
83. Perez O., et al. Novel adjuvant based on a proteoliposome-derived cochleate structure containing native lipopolysaccharide as a pathogen-associated molecular pattern. Immunol. Cell Biol. 2004, 82:603-610.
84. Casella C.R., Mitchell T.C. Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant. Cell Mol. Life Sci. 2008, 65:3231-3240.
85. Khader S.A., et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat. Immunol. 2007, 8:369-377.
86. Enioutina E.Y., et al. TLR-induced local metabolism of vitamin D3 plays an important role in the diversification of adaptive immune responses. J. Immunol. 2009, 182:4296-4305.
87. Verstraeten T., et al. Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines. Vaccine 2008, 26:6630-6638.
88. Di Paolo, D. et al. (2010) One-year vaccination against hepatitis B virus with a MPL-vaccine in liver transplant patients for HBV-related cirrhosis. Transpl. Int. [details missing]. doi:10.1111/j.1432-2277.2010.01104.x.
89. Vandepapeliere P., et al. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers. Vaccine 2008, 26:1375-1386.
90. Zughaier S.M., et al. Differential induction of the toll-like receptor 4-MyD88-dependent and -independent signaling pathways by endotoxins. Infect. Immun. 2005, 73:2940-2950.
91. Fedele G., et al. Lipopolysaccharides from Bordetella pertussis and Bordetella parapertussis differently modulate human dendritic cell functions resulting in divergent prevalence of Th17-polarized responses. J. Immunol. 2008, 181:208-216.
92. Hashimoto S.I., et al. Identification of genes specifically expressed in human activated and mature dendritic cells through serial analysis of gene expression. Blood 2000, 96:2206-2214.
93. Schuetze N., et al. IL-12 family members: differential kinetics of their TLR4-mediated induction by Salmonella enteritidis and the impact of IL-10 in bone marrow-derived macrophages. Int. Immunol. 2005, 17:649-659.
94. Collison L.W., et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 2007, 450:566-569.